BHCM
CNMD icon

Brevan Howard Capital Management’s CONMED CNMD Stock Holding History

Brevan Howard Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,291
Closed -$1.67M – 2149
2026
Q1 		$1.67M Buy
47,291
+21,284
+82% +$866K 0.01% 640
2025
Q4 		$1.06M Buy
+26,007
New +$1.13M 0.01% 738
2025
Q1 		– Sell
-12,740
Closed -$872K – 1197
2024
Q4 		$872K Buy
12,740
+8,162
+178% +$569K 0.01% 464
2024
Q3 		$329K Buy
4,578
+1,251
+38% +$88.3K ﹤0.01% 814
2024
Q2 		$231K Sell
3,327
-2,503
-43% -$183K ﹤0.01% 854
2024
Q1 		$467K Buy
+5,830
New +$520K ﹤0.01% 485

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Brevan Howard Capital Management's CNMD Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of CONMED (CNMD) in Q2 2026, closing a stake of 47,291 shares — an estimated $1.67M sold.

Brevan Howard Capital Management first reported a position in CNMD in Q1 2024 and held it in 6 quarters. The position peaked at $1.67M in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 47,291 CONMED shares in Q2 2026, an estimated $1.67M.
  • Brevan Howard Capital Management first reported a position in CONMED in Q1 2024 and held it in 6 quarters.
  • Brevan Howard Capital Management's CONMED position peaked at $1.67M in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.